Immunologic Aspects of Heart Disease

DeCarvalho, Sergio
July 1982
Angiology;Jul1982, Vol. 33 Issue 7, p427
Academic Journal
All forms of heart disease, whether caused by streptococcus group A, aseptic heart injury, virus, hypersensitivity, autoimmune conditions, or graftversus- host reactions, have in common allogenic transformation of the myocardial cell membrane and production of multifunctional autoantibodies, in addition to cause-specific antibodies, some of which cross-react with heart tissue. The outcome of this immunologic insult depends on the ability of the host's immunoregulatory mechanisms to dispose swiftly of the offending antigen and antibody or their complexes. Heart disease often results when these mechanisms, exemplified here, are not intact or when they function inappropriately in genetic or acquired settings and in varying haplotype frames.


Related Articles

  • Heat-Killed Trypanosoma cruzi Induces Acute Cardiac Damage and Polyantigenic Autoimmunity. Bonney, Kevin M.; Taylor, Joann M.; Daniels, Melvin D.; Epting, Conrad L.; Engman, David M. // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Chagas heart disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially fatal cardiomyopathy often associated with cardiac autoimmunity. T. cruzi infection induces the development of autoimmunity to a number of antigens via molecular mimicry and other mechanisms, but the...

  • Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. Merbl, Yifat; Zucker-Toledano, Merav; Quintana, Francisco J.; Cohen, Irun R. // Journal of Clinical Investigation;Mar2007, Vol. 117 Issue 3, p712 

    Autoimmune diseases are often marked by autoantibodies binding to self antigens. However, many healthy persons also manifest autoantibodies that bind to self antigens, known as natural autoantibodies. In order to characterize natural autoantibodies present at birth, we used an antigen microarray...

  • Autoantigens for IgA Anti-Intercellular Antibodies of Intercellular IgA Vesiculopustular Dermatosis. Ebihara, Tamotsu; Hashimoto, Takashi; Iwatsuki, Keiji; Takigawa, Masahiro; Ando, Masaaki; Ohkawara, Akira; Nishikawa, Takeji // Journal of Investigative Dermatology;Oct91, Vol. 97 Issue 4, p742 

    A new disease characterized by the presence of in vivo bound and/or circulating IgA anti-intercellular (IC) antibodies has recently been identified. We propose the term intercellular IgA vesiculopustular dermatosis (IAVPD) for this entity, which seems to be divided clinicopathologically into at...

  • Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes. Steinbrenner, H.; Lohmann, T.; Ostendorf, B.; Scherbaum, W. A.; Seissler, J. // Diabetologia;Nov2000, Vol. 43 Issue 11, p1381 

    Aims/hypothesis. The majority of patients with Type I (insulin-dependent) diabetes mellitus has autoantibodies to insulin, glutamic acid decarboxylase and the tyrosine phosphatase-like protein IA-2. Some patients with Type I diabetes, in particular with adult onset diabetes, have, however, only...

  • T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. Datta, Syamal; Li Zhang; Luting Xu // Journal of Molecular Medicine;Apr2005, Vol. 83 Issue 4, p267 

    Special populations of T helper cells drive B cells to produce IgG class switched, pathogenic autoantibodies in lupus. The major source of antigenic determinants (epitopes) that trigger interactions between lupus T and B cells is nucleosomes of apoptotic cells. These epitopes can be used for...

  • Anti-C1q autoantibodies, novel tests, and clinical consequences. Mahler, Michael; van Schaarenburg, Rosanne A.; Trouw, Leendert A. // Frontiers in Immunology;May2013, Vol. 4, p1 

    Although anti-C1q autoantibodies have been described more than four decades ago a constant stream of papers describing clinical associations or functional consequences highlights that anti-C1q antibodies are still hot and happening. By far the largest set of studies focus on anti-C1q antibodies...

  • High Ro52 Expression in Spontaneous and UV-Induced Cutaneous Inflammation. Oke, Vilija; Vassilaki, Ismini; Espinosa, Alexander; Strandberg, Linn; Kuchroo, Vijay K; Nyberg, Filippa; Wahren-Herlenius, Marie // Journal of Investigative Dermatology;Aug2009, Vol. 129 Issue 8, p2000 

    Ro52 is an E3 ubiquitin ligase with a recently identified regulatory role in inflammation. The protein is targeted by autoantibodies in rheumatic diseases, and Ro52 autoantibodies are specifically associated with cutaneous lupus erythematosus (CLE) and photosensitivity. The aim of this study was...

  • Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies. Kobold, Sebastian; Luetkens, Tim; Cao, Yanran; Bokemeyer, Carsten; Atanackovic, Djordje // Clinical & Developmental Immunology;2010, p1 

    There is an urgent need for earlier diagnosis of malignancies and more stringent monitoring of relapses after antitumor therapy. In addition, new prognostic markers are needed for risk stratification and design of individualized cancer therapies. New diagnostic and prognostic parameters should...

  • Oesophageal manometry in early and definite systemic sclerosis. Airò, Paolo; Della Casa, Domenico; Danieli, Elisabetta; Missale, Guido; Cattaneo, Roberto; Cestari, Renzo // Clinical Rheumatology;Aug2005, Vol. 24 Issue 4, p370 

    The objective of this study was to evaluate the oesophageal dysfunction in patients with “early” systemic sclerosis (SSc), as defined by LeRoy and Medsger, to compare it with that of patients with definite SSc, and to correlate it with other features of the disease. Oesophageal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics